These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21631422)

  • 61. Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion.
    Maulik N; Yoshida T; Engelman RM; Deaton D; Flack JE; Rousou JA; Das DK
    Mol Cell Biochem; 1998 Sep; 186(1-2):139-45. PubMed ID: 9774195
    [TBL] [Abstract][Full Text] [Related]  

  • 62. TNFalpha in ischemia/reperfusion injury and heart failure.
    Schulz R; Aker S; Belosjorow S; Heusch G
    Basic Res Cardiol; 2004 Jan; 99(1):8-11. PubMed ID: 14685700
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PPAR-γ and AMPK--advantageous targets for myocardial ischemia/reperfusion therapy.
    Morrison A; Li J
    Biochem Pharmacol; 2011 Aug; 82(3):195-200. PubMed ID: 21536015
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CREG protects from myocardial ischemia/reperfusion injury by regulating myocardial autophagy and apoptosis.
    Song H; Yan C; Tian X; Zhu N; Li Y; Liu D; Liu Y; Liu M; Peng C; Zhang Q; Gao E; Han Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Aug; 1863(8):1893-1903. PubMed ID: 27840305
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases.
    Javadov S; Karmazyn M; Escobales N
    J Pharmacol Exp Ther; 2009 Sep; 330(3):670-8. PubMed ID: 19509316
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Debating new strategies for cardiac protection in the ageing heart in Naples, Italy: news from the joint meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart.
    Pesce M; Bär C; Madonna R; Thum T
    Cardiovasc Res; 2020 Sep; 116(11):1802-1804. PubMed ID: 32666085
    [No Abstract]   [Full Text] [Related]  

  • 67. Novel and emerging therapies in cardiology and haematology.
    Pimanda JE; Lowe HC; Hogg PJ; Chesterman CN; Khachigian LM
    Curr Drug Targets Cardiovasc Haematol Disord; 2003 Jun; 3(2):101-23. PubMed ID: 12769638
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The pediatric cardiology pharmacopeia: 2013 update.
    Severin PN; Awad S; Shields B; Hoffman J; Bonney W; Cortez E; Ganesan R; Patel A; Barnes S; Barnes S; Al-Anani S; Gupta U; Cheddar YB; Gonzalez IE; Mallula K; Ghawi H; Kazmouz S; Gendi S; Abdulla RI
    Pediatr Cardiol; 2013 Jan; 34(1):1-29. PubMed ID: 23192622
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Drugs and the elderly. Update: cardiac emergency drugs.
    Todd B
    Geriatr Nurs; 1986; 7(5):263-8. PubMed ID: 3638252
    [No Abstract]   [Full Text] [Related]  

  • 70. Editorial: Inflammation and Heart Diseases.
    Yue-Chun L
    Curr Pharm Des; 2018; 24(3):259-261. PubMed ID: 29671718
    [No Abstract]   [Full Text] [Related]  

  • 71. Muscle-specific programmed cell death 5 in heart disease: Friend or foe?
    Mu L; Li L; Liu W
    Int J Cardiol; 2022 Jun; 356():87. PubMed ID: 35398234
    [No Abstract]   [Full Text] [Related]  

  • 72. Mechanisms and inhibitors of apoptosis in cardiovascular diseases.
    Singh SS; Kang PM
    Curr Pharm Des; 2011; 17(18):1783-93. PubMed ID: 21631422
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.